195 related articles for article (PubMed ID: 15469393)
1. Targeted treatments for cirrhosis.
Fallowfield JA; Iredale JP
Expert Opin Ther Targets; 2004 Oct; 8(5):423-35. PubMed ID: 15469393
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies for liver fibrosis.
Fowell AJ; Iredale JP
Dig Dis; 2006; 24(1-2):174-83. PubMed ID: 16699275
[TBL] [Abstract][Full Text] [Related]
3. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy.
Li D; Friedman SL
J Gastroenterol Hepatol; 1999 Jul; 14(7):618-33. PubMed ID: 10440206
[TBL] [Abstract][Full Text] [Related]
4. Hepatic fibrosis--role of hepatic stellate cell activation.
Safadi R; Friedman SL
MedGenMed; 2002 Jul; 4(3):27. PubMed ID: 12466770
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of liver fibrosis: a translational success story.
Lee YA; Wallace MC; Friedman SL
Gut; 2015 May; 64(5):830-41. PubMed ID: 25681399
[TBL] [Abstract][Full Text] [Related]
7. Improvement of portal venous pressure in cirrhotic rat livers by systemic treatment with adipose tissue-derived mesenchymal stromal cells.
Brückner S; Zipprich A; Hempel M; Thonig A; Schwill F; Roderfeld M; Roeb E; Christ B
Cytotherapy; 2017 Dec; 19(12):1462-1473. PubMed ID: 29074333
[TBL] [Abstract][Full Text] [Related]
8. Targeting Hepatic Fibrosis in Autoimmune Hepatitis.
Montano-Loza AJ; Thandassery RB; Czaja AJ
Dig Dis Sci; 2016 Nov; 61(11):3118-3139. PubMed ID: 27435327
[TBL] [Abstract][Full Text] [Related]
9. High-fat diet plus carbon tetrachloride-induced liver fibrosis is alleviated by betaine treatment in rats.
Bingül İ; Aydın AF; Başaran-Küçükgergin C; Doğan-Ekici I; Çoban J; Doğru-Abbasoğlu S; Uysal M
Int Immunopharmacol; 2016 Oct; 39():199-207. PubMed ID: 27494683
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis and cirrhosis reversibility - molecular mechanisms.
Gieling RG; Burt AD; Mann DA
Clin Liver Dis; 2008 Nov; 12(4):915-37, xi. PubMed ID: 18984474
[TBL] [Abstract][Full Text] [Related]
11.
Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow cell infusion therapy for liver cirrhosis.
Sakaida I
J Gastroenterol Hepatol; 2008 Sep; 23(9):1349-53. PubMed ID: 18422964
[TBL] [Abstract][Full Text] [Related]
14. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
15. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
17. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
18. Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis.
Jaroszewicz J; Flisiak-Jackiewicz M; Lebensztejn D; Flisiak R
Expert Opin Investig Drugs; 2015; 24(9):1229-39. PubMed ID: 26122697
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking.
Issa R; Zhou X; Constandinou CM; Fallowfield J; Millward-Sadler H; Gaca MD; Sands E; Suliman I; Trim N; Knorr A; Arthur MJ; Benyon RC; Iredale JP
Gastroenterology; 2004 Jun; 126(7):1795-808. PubMed ID: 15188175
[TBL] [Abstract][Full Text] [Related]
20. The Therapeutic Mechanisms of Propolis Against CCl
Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
